This Drug Abuse Warning Network (DAWN) report shows emergency room visits in 2010 involving synthetic cannabinoid products commonly called \"Spice\" or \"K2\". These drugs are also known as synthetic marijuana,
Search Results
This National Survey on Drug Use and Health (NSDUH) short report shows inhalant use by adolescents 12 to 17 years old. It also looks at inhalant use by gender, race, region of the country, metro area, past year use and days used.
This National Survey on Drug Use and Health (NSDUH) short report looks at trends in substance use disorder (SUD) among males aged 18 to 49 on probation or parole during the past 12 months. The report looks those who had an alcohol or illicit drug use disorder, or both, in...
This report presents data from the Treatment Episode Data Set (TEDS) by Census division and State or jurisdiction for admissions in 2011, and trend data for 2001 to 2011. It provides information on the demographic and substance abuse characteristics of admissions to treatment aged 12 and older for abuse of...
These detailed tables are population tobacco and alcohol use totals and prevalence estimates from the 2012 National Survey on Drug Use and Health (NSDUH). Tobacco products include cigarettes, smokeless tobacco, cigars, and pipe tobacco. Alcohol use includes binge and heavy alcohol use. Results are provided for lifetime, past year, and...
These detailed tables present totals and prevalence estimates of substance use initiation from the 2012 National Survey on Drug Use and Health (NSDUH). Substances examined include illicit drugs (e.g., marijuana, cocaine, heroin, hallucinogens (including LSD, PCP, Ecstasy), inhalants, and the nonmedical use of prescription-type pain relievers (including OxyContin), tranquilizers, stimulants...
These detailed tables present totals and prevalence estimates of substance dependence/abuse and treatment need/receipt from the 2012 National Survey on Drug Use and Health (NSDUH). Substances examined include illicit drugs, marijuana, cocaine, heroin, hallucinogens, inhalants, and the nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, and sedatives, and alcohol. Results...
This report presents current and prior methodological approaches for estimating the prevalence of serious mental illness (SMI) and any mental illness (AMI) among adults aged 18 or older using 2008 to 2012 National Survey on Drug Use and Health (NSDUH) data. Revised SMI and AMI estimates for 2012 are presented...
This Data Spotlight focuses on trends in substances of abuse among pregnant women and women of childbearing age (aged 15-44) from 2000 through 2010 using data from the Treatment
Episode Data Set (TEDS).
This is a National Survey of Substance Abuse Treatment Services (N-SSATS) short report about data on substance abuse treatment facilities in 2010.
This is a National Survey of Substance Abuse Treatment Services (N-SSATS) table showing N-SSATS data, by status and mode of response for 2011.
This publication provides behavioral health statistics at the national and state levels from multiple data sources, including the National Survey on Drug Use and Health, the National Health Interview Survey, the Medical Expenditures Panel Survey, the National Association of State Mental Health Program Directors, as well as peer-reviewed journal articles.
These detailed tables are population illicit drug use totals and prevalence estimates from the 2012 National Survey on Drug Use and Health (NSDUH). Illicit drugs include marijuana, cocaine, crack, heroin, hallucinogens, inhalants, and the nonmedical use of prescription-type psychotherapeutics, including pain relievers, tranquilizers, stimulants, and sedatives. Results are provided for...
This issue of the National Survey on Drug Use and Health (NSDUH) Report presents combined 2002 to 2010 data to examine substance use patterns among
This issue of the National Survey on Drug Use and Health (NSDUH) Report presents combined 2008 to 2010 data to examine the prevalence of past year major depressive episode (MDE) among full-time college students and other young adults aged 18 to 22. Data on past year MDE, severity of impairment...